In the Oncomine database, the results showed that LPAR1 was highly expressed in lymphoma while lowly expressed in prostate, bladder, brain, colon, head and neck, kidney, leukemia, lung, melanoma, and ovarian cancers. Here, LPAR1 is linked to ovarian carcinoma.